Dashboard
With HIgh Debt (Debt-Equity Ratio at 5.01 times)- the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -10.47% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 2.37 times
- The company has been able to generate a Return on Equity (avg) of 7.51% signifying low profitability per unit of shareholders funds
Flat results in Sep 25
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 8 Cr (Micro Cap)
136.00
37
0.00%
5.01
2.87%
1.99
Total Returns (Price + Dividend) 
C J Gelatine for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Closure of Trading Window
26-Mar-2026 | Source : BSEThe Trading Window for the dealing in the Securities of the Company for all the Insiders Designated Person & their immediate Relatives Connected Person Fiduciaries and Intermediaries shall remain closed from April 1 2026 till the expiry of 48 (Forty Eight) hours after the declaration of the Financial Results of the Company for the quarter and year ended March 31 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
09-Feb-2026 | Source : BSEThe Company has published in newspapers the unaudited financial results for the quarter and nine months ended December 31 2025. The same were published within 48 hours of the conclusion of the meeting of the Board of Directors of the Company held on February 7 2026 wherein the aforesaid results were duly approved. Please find attached the same.
Board Meeting Outcome for Meeting Held Today I.E. Saturday February 7 2026
07-Feb-2026 | Source : BSEThe Board of Directors of the Company at their Meeting held on today i.e. Saturday February 7 2026 have inter-alia considered and approved the Unaudited Financial Results / Statements of the Company for the Quarter and Nine Months ended December 31 2025 along-with Limited Review Report. The aforesaid Board Meeting was commenced at 1:30 p.m. (IST) and concluded at 4:00 p.m. (IST).
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Jaspal Singh (57.49%)
Krishan Kumar Amla (4.01%)
35.68%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -15.63% vs 43.25% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 175.00% vs 128.57% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 8.11% vs -5.67% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs 86.11% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 2.71% vs 0.88% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 133.33% vs 98.27% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 0.98% vs 11.11% in Mar 2024
YoY Growth in year ended Mar 2025 is 104.10% vs -947.83% in Mar 2024